1.89
Inhibikase Therapeutics Inc-Aktien (IKT) Preisverlauf
Täglich
Wöchentlich
Monatlich
7T
30T
60T
YTD
1J
| Datum | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2026-01-07 | $2.02 | $1.80 | $0.215 | 566,175.0 | -5.50% |
| 2026-01-06 | $2.10 | $1.94 | $0.155 | 859,669.0 | -0.50% |
| 2026-01-05 | $2.16 | $1.96 | $0.1991 | 842,419.0 | +3.08% |
| 2026-01-02 | $2.09 | $1.94 | $0.1492 | 298,002.0 | -4.88% |
| 2025-12-31 | $2.06 | $1.94 | $0.12 | 505,722.0 | +4.06% |
| 2025-12-30 | $2.04 | $1.91 | $0.1298 | 360,784.0 | +0.51% |
| 2025-12-29 | $2.15 | $1.89 | $0.2649 | 775,891.0 | -2.00% |
| 2025-12-26 | $2.05 | $1.71 | $0.3441 | 2,074,556.0 | +21.21% |
| 2025-12-24 | $1.69 | $1.58 | $0.105 | 714,975.0 | +3.77% |
| 2025-12-23 | $1.67 | $1.56 | $0.11 | 462,556.0 | -4.22% |
| 2025-12-22 | $1.79 | $1.62 | $0.1695 | 1,288,010.0 | -3.49% |
| 2025-12-19 | $1.75 | $1.60 | $0.15 | 728,861.0 | +2.99% |
| 2025-12-18 | $1.73 | $1.56 | $0.165 | 436,860.0 | +5.03% |
| 2025-12-17 | $1.64 | $1.55 | $0.09 | 609,250.0 | -0.63% |
| 2025-12-16 | $1.67 | $1.51 | $0.1549 | 932,627.0 | -1.23% |
| 2025-12-15 | $1.65 | $1.52 | $0.125 | 930,671.0 | +5.19% |
| 2025-12-12 | $1.56 | $1.50 | $0.06 | 642,175.0 | +0.98% |
| 2025-12-11 | $1.57 | $1.48 | $0.0889 | 490,322.0 | +3.04% |
| 2025-12-10 | $1.51 | $1.44 | $0.07 | 224,063.0 | +1.37% |
| 2025-12-09 | $1.55 | $1.44 | $0.1072 | 242,841.0 | +1.39% |
Inhibikase Therapeutics Inc-Aktien (IKT) Preisverlauf Jahr für Jahr
In dieser detaillierten Analyse präsentieren wir einen umfassenden Überblick über die Kursbewegungen der Inhibikase Therapeutics Inc-Aktie im Laufe der Jahre. Durch die Untersuchung der Jahresdaten können Investoren wertvolle Einblicke in die historische Performance und Volatilität der IKT-Aktien gewinnen. Von bedeutenden Meilensteinen und Schwankungen bis hin zu bemerkenswerten Trends bietet diese gründliche Untersuchung der Preisgeschichte der Inhibikase Therapeutics Inc-Aktie eine Grundlage für das Verständnis der Entwicklung der Aktien des Unternehmens im Laufe der Zeit.
Inhibikase Therapeutics Inc-Aktien (IKT) Preisverlauf 2026
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2026-01 | $2.16 | $1.80 | $0.3591 | 3,132,440.0 | -7.80% |
Inhibikase Therapeutics Inc-Aktien (IKT) Preisverlauf 2025
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2025-12 | $2.15 | $1.40 | $0.7499 | 12,649,333.0 | +29.61% |
| 2025-11 | $1.76 | $1.33 | $0.43 | 6,426,701.0 | +3.40% |
| 2025-10 | $1.75 | $1.43 | $0.32 | 2,118,256.0 | -9.26% |
| 2025-09 | $1.84 | $1.47 | $0.37 | 3,037,472.0 | -10.00% |
| 2025-08 | $1.90 | $1.42 | $0.485 | 2,104,235.0 | +13.92% |
| 2025-07 | $2.09 | $1.56 | $0.5253 | 2,811,958.0 | -18.97% |
| 2025-06 | $2.13 | $1.56 | $0.57 | 10,240,398.0 | -2.99% |
| 2025-05 | $2.37 | $1.70 | $0.665 | 2,518,541.0 | -11.06% |
| 2025-04 | $2.29 | $1.54 | $0.755 | 2,943,425.0 | +3.20% |
| 2025-03 | $2.58 | $1.91 | $0.67 | 2,550,093.0 | -4.78% |
| 2025-02 | $3.32 | $2.03 | $1.29 | 3,719,760.0 | +1.32% |
| 2025-01 | $3.49 | $1.90 | $1.59 | 3,837,967.0 | -30.15% |
Inhibikase Therapeutics Inc-Aktien (IKT) Preisverlauf 2024
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2024-12 | $4.20 | $2.57 | $1.63 | 8,862,145.0 | +10.96% |
| 2024-11 | $3.69 | $1.75 | $1.94 | 5,718,271.0 | +15.42% |
| 2024-10 | $2.80 | $1.15 | $1.65 | 25,963,526.0 | +94.62% |
| 2024-09 | $1.51 | $1.12 | $0.39 | 382,272.0 | -7.14% |
| 2024-08 | $1.59 | $1.16 | $0.43 | 482,365.0 | -0.71% |
| 2024-07 | $1.73 | $1.13 | $0.60 | 683,589.0 | +16.53% |
| 2024-06 | $1.92 | $1.17 | $0.75 | 398,256.0 | -34.24% |
| 2024-05 | $2.22 | $1.20 | $1.02 | 1,532,322.0 | +25.17% |
| 2024-04 | $2.30 | $1.29 | $1.01 | 1,251,244.0 | -31.94% |
| 2024-03 | $2.49 | $1.80 | $0.69 | 1,021,896.0 | +0.00% |
| 2024-02 | $3.35 | $2.02 | $1.33 | 3,716,352.0 | -28.37% |
| 2024-01 | $3.82 | $1.26 | $2.56 | 4,185,073.0 | +137.44% |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):